Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. R. Wijsman

Publicaties

Developing a prediction model for adjuvant immunotherapy post-chemoradiation in stage III inoperable non-small-cell lung cancer

Dose-related cardiac side effects and its impact on survival following thoracic radiotherapy: A scoping review

An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy

Coronary artery calcification in thoracic cancer radiotherapy: A scoping review

Dose-based evaluation of delineation variation in radiotherapy: A scoping review

External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients

Patient selection for proton therapy in lung cancer: Nationwide external validation and model update of a prognostic model for 2-year mortality including mean heart dose

Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLC

Real-World Data on Once or Twice-Daily Radiation Therapy and the Effect of Age in Patients With Limited-Stage Small-Cell Lung Cancer

Stage I non-small cell lung cancer: improving patient selection for minimally invasive lobectomy or stereotactic ablative radiotherapy based on clinical characteristics

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.